Stay updated on COTEZO IMblaze370 Clinical Trial

Sign up to get notified when there's something new on the COTEZO IMblaze370 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the COTEZO IMblaze370 Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The NIH transition announcement banner was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-07T12:28:55.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:24:33.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T13:04:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:58:25.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:03:23.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study details are currently inaccessible. This suggests an access restriction or server-side issue preventing the study information from loading.
    Difference
    0.5%
    Check dated 2026-09-26T16:03:03.000Z thumbnail image

Stay in the know with updates to COTEZO IMblaze370 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the COTEZO IMblaze370 Clinical Trial page.